With Winrevair Approved, Merck Has A Chance To Execute On CV Strategy
The WAC price of Winrevair is $14,000 per vial
The activin signaling inhibitor sotatercept was approved by the US FDA for pulmonary arterial hypertension.
The activin signaling inhibitor sotatercept was approved by the US FDA for pulmonary arterial hypertension.